RU2567660C2 - Bifidobacterium longum ATCC BAA-999 (BL999) И КОНТРОЛИРОВАНИЕ ВЕСА - Google Patents
Bifidobacterium longum ATCC BAA-999 (BL999) И КОНТРОЛИРОВАНИЕ ВЕСА Download PDFInfo
- Publication number
- RU2567660C2 RU2567660C2 RU2012117804/10A RU2012117804A RU2567660C2 RU 2567660 C2 RU2567660 C2 RU 2567660C2 RU 2012117804/10 A RU2012117804/10 A RU 2012117804/10A RU 2012117804 A RU2012117804 A RU 2012117804A RU 2567660 C2 RU2567660 C2 RU 2567660C2
- Authority
- RU
- Russia
- Prior art keywords
- composition
- use according
- bifidobacterium longum
- longum atcc
- atcc baa
- Prior art date
Links
- 241001608472 Bifidobacterium longum Species 0.000 title claims abstract description 57
- 229940009291 bifidobacterium longum Drugs 0.000 title claims abstract description 52
- 238000004260 weight control Methods 0.000 title description 6
- 239000000203 mixture Substances 0.000 claims abstract description 103
- 241001465754 Metazoa Species 0.000 claims abstract description 11
- 235000013305 food Nutrition 0.000 claims description 32
- 241000894006 Bacteria Species 0.000 claims description 30
- 229920001542 oligosaccharide Polymers 0.000 claims description 24
- 150000002482 oligosaccharides Chemical class 0.000 claims description 24
- 208000008589 Obesity Diseases 0.000 claims description 16
- 235000020824 obesity Nutrition 0.000 claims description 16
- 235000013406 prebiotics Nutrition 0.000 claims description 13
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000008194 pharmaceutical composition Substances 0.000 claims description 7
- 230000002265 prevention Effects 0.000 claims description 7
- 206010033307 Overweight Diseases 0.000 claims description 6
- 235000013325 dietary fiber Nutrition 0.000 claims description 6
- 208000030159 metabolic disease Diseases 0.000 claims description 6
- 230000004580 weight loss Effects 0.000 claims description 6
- 241000186000 Bifidobacterium Species 0.000 claims description 5
- 229920001202 Inulin Polymers 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 4
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 4
- 229940029339 inulin Drugs 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 229930091371 Fructose Natural products 0.000 claims description 3
- 239000005715 Fructose Substances 0.000 claims description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 235000019260 propionic acid Nutrition 0.000 claims description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 20
- 239000000126 substance Substances 0.000 abstract description 6
- 239000013585 weight reducing agent Substances 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 4
- 238000004321 preservation Methods 0.000 abstract 1
- 239000006041 probiotic Substances 0.000 description 17
- 235000018291 probiotics Nutrition 0.000 description 17
- 241000699670 Mus sp. Species 0.000 description 14
- 230000000529 probiotic effect Effects 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 230000037396 body weight Effects 0.000 description 9
- 239000003925 fat Substances 0.000 description 9
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 9
- 150000003271 galactooligosaccharides Chemical class 0.000 description 9
- 239000000843 powder Substances 0.000 description 8
- 244000005709 gut microbiome Species 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000000758 substrate Substances 0.000 description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 5
- 239000004472 Lysine Substances 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 238000012423 maintenance Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 108010046377 Whey Proteins Proteins 0.000 description 4
- 102000007544 Whey Proteins Human genes 0.000 description 4
- 210000000577 adipose tissue Anatomy 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000019786 weight gain Nutrition 0.000 description 4
- 230000037221 weight management Effects 0.000 description 4
- 241000186012 Bifidobacterium breve Species 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- 239000005862 Whey Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- -1 flavorings Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 102000002268 Hexosaminidases Human genes 0.000 description 2
- 108010000540 Hexosaminidases Proteins 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- OVRNDRQMDRJTHS-BKJPEWSUSA-N N-acetyl-D-hexosamine Chemical compound CC(=O)NC1C(O)O[C@H](CO)C(O)C1O OVRNDRQMDRJTHS-BKJPEWSUSA-N 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 102000004357 Transferases Human genes 0.000 description 2
- 108090000992 Transferases Proteins 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 235000020244 animal milk Nutrition 0.000 description 2
- 230000001847 bifidogenic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 235000013350 formula milk Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 238000009629 microbiological culture Methods 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 229940001941 soy protein Drugs 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- OIZGSVFYNBZVIK-FHHHURIISA-N 3'-sialyllactose Chemical compound O1[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C[C@@]1(C(O)=O)O[C@@H]1[C@@H](O)[C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]1O OIZGSVFYNBZVIK-FHHHURIISA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 238000011640 AKR mouse Methods 0.000 description 1
- 102000002281 Adenylate kinase Human genes 0.000 description 1
- 108020000543 Adenylate kinase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 102000030902 Galactosyltransferase Human genes 0.000 description 1
- 108060003306 Galactosyltransferase Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000051366 Glycosyltransferases Human genes 0.000 description 1
- 108700023372 Glycosyltransferases Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920001732 Lignosulfonate Polymers 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108010070551 Meat Proteins Proteins 0.000 description 1
- 201000010859 Milk allergy Diseases 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108010084695 Pea Proteins Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 235000019904 Raftiline® Nutrition 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 102000003838 Sialyltransferases Human genes 0.000 description 1
- 108090000141 Sialyltransferases Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229920001938 Vegetable gum Polymers 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- LKDRXBCSQODPBY-ZXXMMSQZSA-N alpha-D-fructopyranose Chemical compound OC[C@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-ZXXMMSQZSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229940009289 bifidobacterium lactis Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000010352 biotechnological method Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000020140 chocolate milk drink Nutrition 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- ORYOIBJWFDNIPD-UHFFFAOYSA-N diacetyl 2,3-dihydroxybutanedioate Chemical class CC(=O)OC(=O)C(O)C(O)C(=O)OC(C)=O ORYOIBJWFDNIPD-UHFFFAOYSA-N 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019541 flavored milk drink Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000009474 immediate action Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 150000002574 ketohexoses Chemical class 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000013116 obese mouse model Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 235000019702 pea protein Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 229960002181 saccharomyces boulardii Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011257 shell material Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 239000006068 taste-masking agent Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09171866.8 | 2009-09-30 | ||
| EP09171866A EP2308499A1 (en) | 2009-09-30 | 2009-09-30 | Bifidobacterium longum ATCC BAA-999 (BL999) and weight control |
| PCT/EP2010/064348 WO2011039176A1 (en) | 2009-09-30 | 2010-09-28 | Bifidobacterium longum atcc baa-999 (bl999) and weight control |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2012117804A RU2012117804A (ru) | 2013-11-20 |
| RU2567660C2 true RU2567660C2 (ru) | 2015-11-10 |
Family
ID=41683555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012117804/10A RU2567660C2 (ru) | 2009-09-30 | 2010-09-28 | Bifidobacterium longum ATCC BAA-999 (BL999) И КОНТРОЛИРОВАНИЕ ВЕСА |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20120244125A1 (enExample) |
| EP (2) | EP2308499A1 (enExample) |
| JP (1) | JP5911424B2 (enExample) |
| CN (1) | CN102665737A (enExample) |
| AR (1) | AR078485A1 (enExample) |
| AU (1) | AU2010303020B2 (enExample) |
| BR (1) | BR112012007109A2 (enExample) |
| CA (1) | CA2775976A1 (enExample) |
| CL (1) | CL2012000809A1 (enExample) |
| IN (1) | IN2012DN02463A (enExample) |
| MX (1) | MX2012003612A (enExample) |
| PH (1) | PH12012500569A1 (enExample) |
| RU (1) | RU2567660C2 (enExample) |
| SG (1) | SG10201406169VA (enExample) |
| WO (1) | WO2011039176A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011114916A1 (ja) * | 2010-03-18 | 2011-09-22 | 森永乳業株式会社 | 貧血の予防又は治療用組成物 |
| EP2452575A1 (en) * | 2010-11-15 | 2012-05-16 | Nestec S.A. | Array of age-tailored nutritional formula with probiotics |
| FI20116008A0 (fi) * | 2011-10-12 | 2011-10-12 | Maeyrae Maekinen Annika | Viskeraalisen rasvan estäminen ja diagnostisointi |
| US9820504B2 (en) | 2013-03-08 | 2017-11-21 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
| BR112015020977A2 (pt) | 2013-03-08 | 2017-07-18 | Axiom Foods Inc | suplemento de proteína de arroz e métodos de uso do mesmo |
| JP6234331B2 (ja) * | 2014-06-13 | 2017-11-22 | 森永乳業株式会社 | 統合失調症治療剤 |
| TWI572713B (zh) * | 2014-10-31 | 2017-03-01 | 豐華生物科技股份有限公司 | 抗肥胖之乳酸菌菌株及其於食品組成物以及醫藥組成物之應用 |
| JP6650728B2 (ja) * | 2015-03-06 | 2020-02-19 | 株式会社ファンケル | ダイエット用の製剤 |
| EP3386523B1 (en) * | 2015-12-11 | 2019-10-09 | Alimentary Health Limited | Bifidobacterium longum for treating obesity and associated metabolic disorders |
| JP6847577B2 (ja) * | 2015-12-28 | 2021-03-24 | 森永乳業株式会社 | ビフィドバクテリウム属細菌および／または乳酸菌の増殖促進および／または減少抑制剤 |
| KR102548553B1 (ko) * | 2016-04-14 | 2023-06-27 | 듀폰 뉴트리션 바이오사이언시즈 에이피에스 | 제지방 체중을 증가시키기 위한 비피더스균 |
| IT201600105831A1 (it) * | 2016-10-20 | 2018-04-20 | Probiotical Spa | Una composizione a base di un estratto di Irvingia gabonensis e ceppi di Bifidobatteri per la regolazione e riduzione del peso corporeo |
| KR101920219B1 (ko) * | 2017-03-08 | 2018-11-20 | 서울대학교산학협력단 | 비피더스균을 포함하는 비만 예방 또는 개선용 조성물 |
| EP3634155A4 (en) | 2017-05-12 | 2021-02-17 | Axiom Foods Inc. | RICE PRODUCTS AND SYSTEMS AND PROCESSES FOR THEIR PRODUCTION |
| CA3073615A1 (en) | 2017-08-25 | 2019-02-28 | University College Cork - National University Of Ireland Cork | Bifidobacterium longum for treating obesity and weight management |
| WO2019087280A1 (ja) * | 2017-10-31 | 2019-05-09 | 森永乳業株式会社 | 筋肉増量用組成物 |
| EP3713587B1 (en) | 2017-11-24 | 2024-03-27 | University College Cork-National University of Ireland, Cork | A composition comprising a cohort of bacteria |
| CN117701424A (zh) * | 2018-04-11 | 2024-03-15 | 韩国生命工学研究院 | 具有肥胖预防或治疗效果的新的鼠李糖乳杆菌菌株及其用途 |
| CN111187734A (zh) * | 2019-12-25 | 2020-05-22 | 生合生物科技（扬州）有限公司 | 长双歧杆菌bl986、由其制备的冻干粉及冻干粉的应用 |
| JP7475155B2 (ja) * | 2020-02-14 | 2024-04-26 | 森永乳業株式会社 | 持久力向上用組成物 |
| WO2021233925A1 (en) * | 2020-05-20 | 2021-11-25 | Société des Produits Nestlé S.A. | Beneficial effect of poaceae and/or leguminoseae fiber on survivability and metabolic activity of bifidobacterium longum |
| EP4070670A1 (en) | 2021-04-08 | 2022-10-12 | University College Cork-National University of Ireland Cork | Lacticaseibacillus paracasei em025-11 and uses thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1974734A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics for reduction of risk of obesity |
| WO2009021824A1 (en) * | 2007-08-10 | 2009-02-19 | Nestec S.A. | Lactobacillus rhamnosus and weight control |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61109729A (ja) * | 1984-11-05 | 1986-05-28 | Advance Res & Dev Co Ltd | コレステロ−ル低下剤 |
| JP2687229B2 (ja) * | 1988-11-11 | 1997-12-08 | 株式会社ヤクルト本社 | 血圧降下剤 |
| JP4280016B2 (ja) * | 2002-02-28 | 2009-06-17 | 雪印乳業株式会社 | 糖尿病合併症予防・改善・治療剤 |
| JP2003252771A (ja) * | 2002-03-04 | 2003-09-10 | Snow Brand Milk Prod Co Ltd | 加齢に伴う代謝異常疾患の予防・改善・治療剤 |
| SE529185C2 (sv) * | 2005-10-07 | 2007-05-22 | Arla Foods Amba | Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt |
| JP2007169200A (ja) * | 2005-12-21 | 2007-07-05 | Morinaga Milk Ind Co Ltd | インフルエンザ感染予防のための医薬及び飲食品 |
| RU2008134892A (ru) * | 2006-01-27 | 2010-03-10 | Даниско А/С (Dk) | Применение пробиотичеких микроорганизмов для лечения и профилактики ожирения и связанных с ним расстройств |
| ES2381211T3 (es) * | 2006-02-15 | 2012-05-24 | Nestec S.A. | Uso del Bifidobacterium longum para prevenir y tratar inflamaciones |
| EP2002842B1 (en) * | 2006-03-31 | 2012-04-11 | Morinaga Milk Industry Co., Ltd. | Method for production of the interleukin production regulator |
| KR20080075971A (ko) * | 2007-02-14 | 2008-08-20 | (주)네오팜 | 프로바이오틱스 복합 제제 |
| UA30077U (uk) * | 2007-10-18 | 2008-02-11 | Одесская Национальная Академия Пищевых Технологий | Композиція для йогурту діабетичного призначення |
| UA31009U (uk) * | 2007-10-18 | 2008-03-25 | Одесская Национальная Академия Пищевых Технологий | Кисломолочний напій діабетичного призначення |
| JP2009143820A (ja) * | 2007-12-12 | 2009-07-02 | Tsujido Chemical Corp | 高尿酸血症の予防または改善剤 |
-
2009
- 2009-09-30 EP EP09171866A patent/EP2308499A1/en not_active Withdrawn
-
2010
- 2010-09-28 AU AU2010303020A patent/AU2010303020B2/en not_active Ceased
- 2010-09-28 WO PCT/EP2010/064348 patent/WO2011039176A1/en not_active Ceased
- 2010-09-28 RU RU2012117804/10A patent/RU2567660C2/ru not_active IP Right Cessation
- 2010-09-28 BR BR112012007109A patent/BR112012007109A2/pt not_active IP Right Cessation
- 2010-09-28 PH PH1/2012/500569A patent/PH12012500569A1/en unknown
- 2010-09-28 EP EP10760993A patent/EP2482829A1/en not_active Withdrawn
- 2010-09-28 IN IN2463DEN2012 patent/IN2012DN02463A/en unknown
- 2010-09-28 CN CN2010800437884A patent/CN102665737A/zh active Pending
- 2010-09-28 US US13/499,535 patent/US20120244125A1/en not_active Abandoned
- 2010-09-28 SG SG10201406169VA patent/SG10201406169VA/en unknown
- 2010-09-28 CA CA2775976A patent/CA2775976A1/en not_active Abandoned
- 2010-09-28 JP JP2012531354A patent/JP5911424B2/ja not_active Ceased
- 2010-09-28 MX MX2012003612A patent/MX2012003612A/es not_active Application Discontinuation
- 2010-09-30 AR ARP100103572A patent/AR078485A1/es unknown
-
2012
- 2012-03-30 CL CL2012000809A patent/CL2012000809A1/es unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1974734A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics for reduction of risk of obesity |
| WO2009021824A1 (en) * | 2007-08-10 | 2009-02-19 | Nestec S.A. | Lactobacillus rhamnosus and weight control |
Non-Patent Citations (1)
| Title |
|---|
| AMENTA M. ET AL. Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight). // Acta Biomed. 2006 Dec;77(3):157-62.ШЕНДЕРОВ Б.А. Медицинская микробная экология и функциональное питание. Том II. Социально-экологические и клинические последствия дисбаланса микробной экологии человека и жиовтных. М.: Издательство Грантъ, 1998, с. 127-130 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CL2012000809A1 (es) | 2012-07-13 |
| AU2010303020B2 (en) | 2014-11-20 |
| BR112012007109A2 (pt) | 2016-07-05 |
| US20120244125A1 (en) | 2012-09-27 |
| RU2012117804A (ru) | 2013-11-20 |
| SG10201406169VA (en) | 2014-11-27 |
| AU2010303020A1 (en) | 2012-04-19 |
| EP2308499A1 (en) | 2011-04-13 |
| PH12012500569A1 (en) | 2012-10-22 |
| JP2013506631A (ja) | 2013-02-28 |
| CN102665737A (zh) | 2012-09-12 |
| IN2012DN02463A (enExample) | 2015-05-22 |
| EP2482829A1 (en) | 2012-08-08 |
| AR078485A1 (es) | 2011-11-09 |
| JP5911424B2 (ja) | 2016-04-27 |
| MX2012003612A (es) | 2012-04-19 |
| WO2011039176A1 (en) | 2011-04-07 |
| CA2775976A1 (en) | 2011-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2567660C2 (ru) | Bifidobacterium longum ATCC BAA-999 (BL999) И КОНТРОЛИРОВАНИЕ ВЕСА | |
| AU2010213009B2 (en) | Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control | |
| AU2008288581B2 (en) | Lactobacillus rhamnosus and weight control | |
| CN102316882B (zh) | 瑞士乳杆菌cncm i-4095与体重控制 | |
| US8318150B2 (en) | Lactobacillus rhamnosus CNCM I-4096 and weight control |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20160929 |